Amazon in talks with generic-drug makers
Amazon is holding meetings with makers of generic drugs about its potential entry into the pharmacy space.
According to CNBC, the conversations, including with generics giants Mylan and Sandoz, a unit of Novartis, have been high-level, and the nature of Amazon's plans isn't yet clear.
CNBC reported the conversations are about Amazon taking a role in drug purchasing, potentially disrupting a space now dominated by distributors McKesson, AmerisourceBergen and Cardinal Health. Generics manufacturers are eager to establish a relationship with Amazon as part of 2018 business plans.
Read more about Amazon's plans by clicking here.